Medical Devices Contract Research Organizations Global Opportunity Assessment Competitive Landscape and Market Forecasts to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Thromboembolism - Pipeline Review, H1 2015

Thromboembolism - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 90 pages

Thromboembolism - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Thromboembolism - Pipeline Review, H1 2015', provides an overview of the Thromboembolism's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete ...

Industries: Drug Discovery and Development | Countries: Japan, World

Sedation - Pipeline Review, H1 2015

Sedation - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 49 pages

Sedation - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Sedation - Pipeline Review, H1 2015', provides an overview of the Sedation's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at ...

Industries: Drug Discovery and Development | Countries: Japan, World

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. JCL Bioassay Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug Discovery and Development | Countries: United States, Japan

Linical Co., Ltd. (Symbol:2183) SWOT Analysis, Strategy, Revenues and Profits

Linical Co., Ltd. (Symbol:2183) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Linical Co., Ltd. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug Discovery and Development | Countries: Japan

Mediscience Planning Inc. (Symbol:2182) SWOT Analysis, Strategy, Revenues and Profits

Mediscience Planning Inc. (Symbol:2182) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Mediscience Planning Inc. SWOT Analysis report provides you a strategic ...

Industries: Drug Discovery and Development | Countries: Japan

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates

  • $ 264
  • Industry report
  • by La Merie Publishing
  • January 2015
  • 25 pages

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the development pipeline of novel therapeutics for treatment of NASH. Purchase of ...

Industries: Drug Discovery and Development | Countries: United States, Japan

Thromboembolism - Pipeline Review, H2 2014

Thromboembolism - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 92 pages

Thromboembolism - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Thromboembolism - Pipeline Review, H2 2014', provides an overview of the Thromboembolism's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with ...

Industries: Drug Discovery and Development | Countries: Japan, World

Japanese Encephalitis - Pipeline Review, H2 2014

Japanese Encephalitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 38 pages

Japanese Encephalitis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Japanese Encephalitis - Pipeline Review, H2 2014', provides an overview of the Japanese Encephalitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Japanese ...

Industries: Drug Discovery and Development | Countries: Japan

Mebix, Inc. - Strategic SWOT Analysis Review

Mebix, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Mebix, Inc. (Mebix) is a clinical research service provider. The company provides products, such as CapTool Prime, a support system for clinical trials providing data management services and CapTool PMS, a support system for clinical trials providing post-marketing surveillance of drugs. Mebix ...

Industries: Drug Discovery and Development | Countries: Japan

Hyperuricemia - Pipeline Review, H2 2014

Hyperuricemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 62 pages

Hyperuricemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Hyperuricemia - Pipeline Review, H2 2014', provides an overview of the Hyperuricemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyperuricemia, complete with comparative ...

Industries: Drug Discovery and Development | Countries: World, Japan

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.